Key result
Higher baseline serum albumin linked to ~60% lower odds of poor outcomes post-stroke.
Why the study?
Does baseline serum albumin concentration predict unfavorable outcomes at 3 months post-acute ischemic stroke in Korean patients?
Cohort (n=1,903)
No
Does baseline serum albumin concentration predict unfavorable outcomes at 3 months post-acute ischemic stroke in Korean patients?
Odds Ratio: 0.4 (95% CI 0.3–0.55)
Low baseline serum albumin concentration is a potential risk factor for unfavorable outcomes at 3 months post-acute ischemic stroke.
BACKGROUND: The role of serum albumin concentration as a predictor of prognosis in stroke is controversial. This study examined the association between baseline serum albumin concentration and unfavorable outcomes at 3 months post-acute ischemic stroke (AIS) in Korean patients. METHODS: Data for 1,903 patients with AIS between January 2010 and December 2016 were extracted from a pro-spective registry system at Seoul National University Hospital, South Korea. Univariate and multivariate binary logistic regression models were used to calculate odds ratios (ORs) and 95% confidence intervals (CIs) and estimate the association between baseline serum albumin concentration and unfavorable outcomes at 3 months post-AIS. RESULTS: Multivariable regression analyses showed baseline serum albumin concentration (continuous variable) was significantly associated with unfavorable outcomes at 3 months post-AIS (fully adjusted OR = 0.4 [95% CI: 0.3 - 0.55]). Analysis of baseline serum albumin concentration as a categorical variable gave consistent results. Curve fitting showed a potential linear association between baseline serum albumin concentration and unfavorable outcomes at 3 months post-AIS (P for non-linearity = 0.789). CONCLUSIONS: Low baseline serum albumin concentration is a potential risk factor for unfavorable outcomes at 3 months post-AIS in Korean patients.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2026) conducted a cohort in Acute ischemic stroke (n=1,903). Baseline serum albumin concentration was evaluated on Unfavorable outcomes at 3 months post-acute ischemic stroke (OR 0.4, 95% CI 0.3-0.55). Baseline serum albumin concentration was significantly and linearly associated with unfavorable outcomes at 3 months post-acute ischemic stroke (OR 0.4; 95% CI 0.3-0.55).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: